Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 288

2.

The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.

Izumi KM, Cahir McFarland ED, Riley EA, Rizzo D, Chen Y, Kieff E.

J Virol. 1999 Dec;73(12):9908-16.

PMID:
10559303
[PubMed - indexed for MEDLINE]
Free PMC Article
4.
5.

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.

Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G.

Mol Cell Biol. 1996 Dec;16(12):7098-108.

PMID:
8943365
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.

Kaye KM, Izumi KM, Li H, Johannsen E, Davidson D, Longnecker R, Kieff E.

J Virol. 1999 Dec;73(12):10525-30.

PMID:
10559372
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.

Devergne O, Cahir McFarland ED, Mosialos G, Izumi KM, Ware CF, Kieff E.

J Virol. 1998 Oct;72(10):7900-8.

PMID:
9733827
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

Cahir McFarland ED, Izumi KM, Mosialos G.

Oncogene. 1999 Nov 22;18(49):6959-64. Review.

PMID:
10602470
[PubMed - indexed for MEDLINE]
Free Article
9.

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.

Kilger E, Kieser A, Baumann M, Hammerschmidt W.

EMBO J. 1998 Mar 16;17(6):1700-9.

PMID:
9501091
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

NF-kappaB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells.

Liljeholm S, Hughes K, Grundström T, Brodin P.

J Gen Virol. 1998 Sep;79 ( Pt 9):2117-25.

PMID:
9747720
[PubMed - indexed for MEDLINE]
Free Article
11.

Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.

Harada S, Yalamanchili R, Kieff E.

J Virol. 1998 Dec;72(12):9948-54.

PMID:
9811732
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

LMP1 TRAFficking activates growth and survival pathways.

Soni V, Cahir-McFarland E, Kieff E.

Adv Exp Med Biol. 2007;597:173-87. Review.

PMID:
17633026
[PubMed - indexed for MEDLINE]
13.

Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.

Eliopoulos AG, Blake SM, Floettmann JE, Rowe M, Young LS.

J Virol. 1999 Feb;73(2):1023-35.

PMID:
9882303
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.

Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS.

Oncogene. 1997 Jun 19;14(24):2899-916.

PMID:
9205097
[PubMed - indexed for MEDLINE]
Free Article
15.

The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.

Fries KL, Miller WE, Raab-Traub N.

Virology. 1999 Nov 10;264(1):159-66.

PMID:
10544141
[PubMed - indexed for MEDLINE]
Free Article
16.

Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.

Franken M, Devergne O, Rosenzweig M, Annis B, Kieff E, Wang F.

J Virol. 1996 Nov;70(11):7819-26.

PMID:
8892903
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production.

Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, Young LS.

J Biol Chem. 1999 Jun 4;274(23):16085-96.

PMID:
10347160
[PubMed - indexed for MEDLINE]
Free Article
18.

A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.

Adriaenssens E, Mougel A, Goormachtigh G, Loing E, Fafeur V, Auriault C, Coll J.

Oncogene. 2004 Apr 8;23(15):2681-93. Erratum in: Oncogene. 2004 Oct 21;23(49):8184.

PMID:
14767477
[PubMed - indexed for MEDLINE]
19.

Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.

Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, Hammerschmidt W.

Cancer Res. 2003 Jun 1;63(11):2982-9.

PMID:
12782607
[PubMed - indexed for MEDLINE]
Free Article
20.

Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.

Le Clorennec C, Ouk TS, Youlyouz-Marfak I, Panteix S, Martin CC, Rastelli J, Adriaenssens E, Zimber-Strobl U, Coll J, Feuillard J, Jayat-Vignoles C.

J Virol. 2008 Jul;82(13):6721-33. doi: 10.1128/JVI.02250-07. Epub 2008 Apr 30.

PMID:
18448526
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk